Ibsium

Irritable Bowel Syndrome is a gastrointestinal disorder which affects over a tenth of the worldwide population. For those affected with IBS, it can be a great burden with symptoms including abdominal pain, bloating, cramping and excess gas. The main cause of IBS remains unknown, therefore diagnosis is a challenge and treatment is an even bigger challenge since treatment options are limited. IBSIUM particularly targets abdominal pain with its specific and exclusive strain of Saccharomyces cerevisiae, which is the first studied yeast with a known mechanism of action on intestinal pain. By activating intestinal PPAR-x receptors, IBSIUM suppresses the pain sensory neurons, which in turn minimizes abdominal pain and reduces bloating. In addition, IBSIUM can help improve stool consistency and frequency